How artificial intelligence could redefine clinical trials in cardiovascular medicine: lessons learned from oncology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How artificial intelligence could redefine clinical trials in cardiovascular medicine: lessons learned from oncology
Authors
Keywords
-
Journal
Personalized Medicine
Volume 16, Issue 2, Pages 83-88
Publisher
Future Medicine Ltd
Online
2019-03-06
DOI
10.2217/pme-2018-0130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension
- (2018) Chayakrit Krittanawong et al. CURRENT HYPERTENSION REPORTS
- The NCI-MATCH trial and precision medicine in gynecologic cancers
- (2018) Lisa Barroilhet et al. GYNECOLOGIC ONCOLOGY
- The next generation of precision medicine: observational studies, electronic health records, biobanks and continuous monitoring
- (2018) Benjamin S Glicksberg et al. HUMAN MOLECULAR GENETICS
- Artificial Intelligence in Cardiology
- (2018) Kipp W. Johnson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial
- (2018) Michael J. Mack et al. AMERICAN HEART JOURNAL
- Artificial Intelligence in Precision Cardiovascular Medicine
- (2017) Chayakrit Krittanawong et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Why clinical trial outcomes fail to translate into benefits for patients
- (2017) Carl Heneghan et al. Trials
- The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
- (2016) Vassiliki Papadimitrakopoulou et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitigating the Effects of Nonadherence in Clinical Trials
- (2016) Thomas M. Shiovitz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Adaptive Designs for Clinical Trials
- (2016) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
- (2016) Thomas J. Hwang et al. JAMA Internal Medicine
- Lung Master Protocol (Lung-MAP)--A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
- (2015) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials
- (2015) R. Miotto et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating Many Treatments and Biomarkers in Oncology: A New Design
- (2013) Richard Kaplan et al. JOURNAL OF CLINICAL ONCOLOGY
- The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
- (2011) Elizabeth O Lillie et al. Personalized Medicine
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now